These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2574479)

  • 21. 8-OH-DPAT and buspirone analogs inhibit the ketanserin-sensitive quipazine-induced head shake response in rats.
    Yocca FD; Wright RN; Margraf RR; Eison AS
    Pharmacol Biochem Behav; 1990 Jan; 35(1):251-4. PubMed ID: 2138331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.
    Eison AS; Eison MS; Stanley M; Riblet LA
    Pharmacol Biochem Behav; 1986 Mar; 24(3):701-7. PubMed ID: 2871564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.
    Fernández-Guasti A; López-Rubalcava C
    Psychopharmacology (Berl); 1990; 101(3):354-8. PubMed ID: 1972996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice.
    Hendrie CA; Shepherd JK; Rodgers RJ
    Neuropharmacology; 1989 Oct; 28(10):1025-32. PubMed ID: 2812281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: a search for the influence of diazepam and 5-HT1A agonists.
    Wedzony K; Maćkowiak M; Fijał K; Gołembiowska K
    Synapse; 1996 Nov; 24(3):240-7. PubMed ID: 8923664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of non-opioid analgesia in intruder mice by selective neuronal and non-neuronal benzodiazepine recognition site ligands.
    Rodgers RJ; Randall JI
    Psychopharmacology (Berl); 1988; 96(1):45-54. PubMed ID: 2852378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonflict effects of acute and chronic treatments with buspirone and gepirone in rats.
    Yamashita S; Oishi R; Gomita Y
    Pharmacol Biochem Behav; 1995 Mar; 50(3):477-9. PubMed ID: 7617689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.
    Ryan CN; Evenden JL; Petterson M
    Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT1A agonists uncouple noradrenergic somatodendritic impulse flow and terminal release.
    Broderick PA; Piercey MF
    Brain Res Bull; 1991 Nov; 27(5):693-6. PubMed ID: 1684526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of novel ligands for 5-HT receptor subtypes on nonopioid defensive analgesia in male mice.
    Rodgers RJ; Shepherd JK; Donát P
    Neurosci Biobehav Rev; 1991; 15(4):489-95. PubMed ID: 1792010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists.
    Li Q; Rittenhouse PA; Levy AD; Alvarez Sanz MC; Van de Kar LD
    Neuropharmacology; 1992 Oct; 31(10):983-9. PubMed ID: 1359439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of the effects of some 5-HT1A receptor agonists on the blood pressure of pithed rats.
    Castillo C; Bobadilla RA; Ibarra M; Castillo EF; Hong E
    Arch Med Res; 1995; 26(3):251-5. PubMed ID: 8580676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats.
    Millan MJ; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):993-1001. PubMed ID: 1672381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys.
    Gold LH; Balster RL
    Psychopharmacology (Berl); 1992; 108(3):289-94. PubMed ID: 1355922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm.
    Kehne JH; Cassella JV; Davis M
    Psychopharmacology (Berl); 1988; 94(1):8-13. PubMed ID: 2894703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.